HypeCheck

Does Dipeptidyl Peptidase IV (DPP-IV) Inhibition Help With Cognitive Protection?

In animal studies, the DPP-IV inhibitor alogliptin reduced diabetes-related brain inflammation and memory impairment.

Weak Evidence

Evidence Summary

In animal studies, the DPP-IV inhibitor alogliptin reduced diabetes-related brain inflammation and memory impairment.

Effective Dose

20–40 mg/kg/day in rats (no human dose established)

Supporting Studies

Every PMID below is a real paper indexed in PubMed. Click any to read the abstract or full text. These are the specific studies HypeCheck cited to support this claim — verify the chain yourself.

Products Containing Dipeptidyl Peptidase IV (DPP-IV) Inhibition

No products analyzed yet that contain this ingredient.

Other Claims About Dipeptidyl Peptidase IV (DPP-IV) Inhibition